How Much Weight Can You Lose a Month on Wegovy?

Last reviewed: July 7, 2026

Last updated: July 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist that slows stomach emptying and reduces hunger signals in the brain, leading to consistent weight reduction for many patients. Clinical trials show participants lose an average of 15% of body weight over 68 weeks, though monthly results vary widely depending on individual factors. Understanding realistic expectations helps you stay motivated and track progress accurately.

Typical Monthly Weight Loss on Semaglutide Injections

During the first month of semaglutide therapy, many patients experience a weight loss of 2–4 pounds as their body adjusts to the medication and appetite suppression begins. By months two through three, as doses increase during titration, weekly losses often reach 1–2 pounds, resulting in 4–8 pounds lost per month. These early-phase results reflect both water weight reduction and genuine fat loss, with the pace gradually stabilizing after the initial 12 weeks.

Individual variation is significant and depends on starting weight, baseline metabolism, diet quality, and physical activity level. Patients with higher initial body weight typically see faster absolute pound loss in early months, while those closer to goal weight may experience slower rates. Consistency with medication timing and adherence to behavioral changes—like reducing calorie intake and increasing movement—directly influences monthly outcomes.

Factors That Affect Your Personal Weight Loss Rate Each Month

The PlexusDx Precision Peptide Genetic Test analyzes GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Dietary composition matters as much as calorie count; high-protein, low-refined-carbohydrate eating patterns enhance semaglutide's effect by stabilizing blood sugar and reducing cravings. Exercise frequency and intensity, sleep quality, stress levels, and hydration status all modulate weight loss velocity from month to month. Medications you're currently taking, thyroid function, and underlying metabolic conditions can either accelerate or slow your progress, making personalized monitoring essential.

Real-World Semaglutide Weight Loss Timeline: Month by Month

Month one typically involves dose titration starting at 0.25 mg, with initial appetite reduction and 2–4 pounds lost; nausea may occur but usually subsides by week two. Month two sees dose increase to 0.5 mg, with most patients reporting 4–6 pounds lost and noticeably reduced food cravings. By month three, as doses climb toward therapeutic levels (0.75–1 mg), many reach a plateau of 6–8 pounds monthly, and hunger signals remain suppressed throughout the day.

Months four through six represent the stabilization phase, where monthly weight loss often slows to 3–5 pounds as your body weight decreases and metabolic adaptation occurs; this is normal and expected. Months seven onward may see further slowing or plateaus, requiring either dose optimization, dietary adjustments, or increased activity to continue progress. Long-term success depends on building sustainable eating and movement habits that persist after semaglutide therapy ends, ensuring weight maintenance rather than rebound.

Why PlexusDx Compounded Semaglutide Supports Consistent Monthly Results

PlexusDx partners with licensed 503A compounding pharmacies to deliver pharmaceutical-grade semaglutide at predictable dosing, ensuring consistency in monthly weight loss trajectories without the variability sometimes seen with brand medications. Compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan across all dose levels—your dose may need to go up, but your price won't—making long-term therapy financially sustainable and transparent. This pricing model removes barriers to dose optimization, which is critical for maintaining steady monthly progress.

PlexusDx serves all 50 states without insurance requirements or membership fees, and semaglutide is HSA/FSA eligible, broadening access to patients seeking reliable, affordable GLP-1 therapy. Pairing compounded semaglutide with the optional Precision Peptide Genetic Test ($298) allows your provider to personalize your protocol based on your unique peptide pathways, potentially unlocking better monthly weight loss outcomes than a generic approach. Consistent medication quality, transparent pricing, and genetic personalization together create an environment where sustainable monthly progress becomes the norm rather than the exception.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How much weight can I realistically lose in my first month on semaglutide?

Most patients lose 2–4 pounds in month one as the body adjusts to appetite suppression and medication titration begins. This initial loss includes water weight and early fat loss, setting the foundation for 4–8 pounds monthly in subsequent months. Your exact result depends on starting weight, dose, diet, and individual metabolism.

Is 1–2 pounds per week a typical rate on semaglutide injections?

Yes, 1–2 pounds weekly is common during active dose escalation (weeks 2–12), translating to 4–8 pounds monthly. This aligns with clinical trial data showing 15% body weight reduction over 68 weeks of therapy. After the titration phase, rates may slow as your body weight decreases and adaptation occurs.

Does PlexusDx semaglutide cost more if I need higher doses for faster weight loss?

No—PlexusDx compounded semaglutide injections cost a flat $189/mo (or $149/mo on the 6-month plan) regardless of dose level. Your dose may need to go up as your provider optimizes your treatment, but your price won't increase, ensuring affordability at every stage of monthly progress.

What happens if my monthly weight loss slows down after month three?

Metabolic adaptation is normal; slowing is expected as your body weight decreases. PlexusDx providers can adjust dose, review dietary adherence, add movement, or explore complementary therapies. The Precision Peptide Genetic Test can reveal whether alternative peptide pathways (beyond GLP-1) might boost results.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

The Precision Peptide Genetic Test analyzes variants in GIPR, FTO, and MC4R, and 10 other pathways across 49 peptides to reveal your individual appetite and metabolism predispositions. This genetic insight helps providers optimize semaglutide dosing and protocol design, improving the likelihood of consistent, higher monthly weight loss aligned with your biology rather than generic expectations.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Wegovy For Losing Weight

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.